ATYR
Atyr Pharma, Inc.
Clinical-stage biotherapeutics company focused on tRNA synthetase biology
CUSIP: 002120202HealthcareUS1 holder
Total Value
$1.65M
Total Shares
587.4K
Net Share Change
+358.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$1.65M587.4K shares
ADD+358.2K(+156.2%)